BR8700563A - Processo para produzir um polipeptideo selecionado em uma celula de inseto hospedeira adequada;vetor recombinador,celula de inseto infectada,peptideo;molecula de polipeptideo;processo para produzir antigeno de superficie de virus de hepatite b em uma celula de inseto hospedeira adequada;celula de inseto hospedeira modificada,antigeno de superficie de virus de hepatite b - Google Patents

Processo para produzir um polipeptideo selecionado em uma celula de inseto hospedeira adequada;vetor recombinador,celula de inseto infectada,peptideo;molecula de polipeptideo;processo para produzir antigeno de superficie de virus de hepatite b em uma celula de inseto hospedeira adequada;celula de inseto hospedeira modificada,antigeno de superficie de virus de hepatite b

Info

Publication number
BR8700563A
BR8700563A BR8700563A BR8700563A BR8700563A BR 8700563 A BR8700563 A BR 8700563A BR 8700563 A BR8700563 A BR 8700563A BR 8700563 A BR8700563 A BR 8700563A BR 8700563 A BR8700563 A BR 8700563A
Authority
BR
Brazil
Prior art keywords
insect cell
polypeptide
host
recombinator
molecula
Prior art date
Application number
BR8700563A
Other languages
English (en)
Inventor
Mark A Cochran
Original Assignee
Microgenesys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to IE332586A priority Critical patent/IE60285B1/en
Priority to KR1019860011085A priority patent/KR950001993B1/ko
Priority to EP86117649A priority patent/EP0228036A3/en
Priority to JP61303612A priority patent/JPS63167797A/ja
Priority to AU66695/86A priority patent/AU599348B2/en
Application filed by Microgenesys Inc filed Critical Microgenesys Inc
Priority to BR8700563A priority patent/BR8700563A/pt
Publication of BR8700563A publication Critical patent/BR8700563A/pt
Priority to AU64806/90A priority patent/AU6480690A/en
Priority to AU52809/93A priority patent/AU5280993A/en
Priority to AU70329/96A priority patent/AU7032996A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14151—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
BR8700563A 1985-12-18 1987-02-06 Processo para produzir um polipeptideo selecionado em uma celula de inseto hospedeira adequada;vetor recombinador,celula de inseto infectada,peptideo;molecula de polipeptideo;processo para produzir antigeno de superficie de virus de hepatite b em uma celula de inseto hospedeira adequada;celula de inseto hospedeira modificada,antigeno de superficie de virus de hepatite b BR8700563A (pt)

Priority Applications (9)

Application Number Priority Date Filing Date Title
IE332586A IE60285B1 (en) 1985-12-18 1986-12-18 Method for producing selected polypeptides in virally infected insect cells and polypeptides isolated therefrom
KR1019860011085A KR950001993B1 (ko) 1985-12-18 1986-12-18 B형 간염 표면항원의 제조방법
EP86117649A EP0228036A3 (en) 1985-12-18 1986-12-18 Method for producing selected polypeptides in virally infected insect cells and polypeptides isolated therefrom
JP61303612A JPS63167797A (ja) 1985-12-18 1986-12-18 選択された昆虫宿主細胞中で選択されたポリペプチドを製造する方法
AU66695/86A AU599348B2 (en) 1985-12-18 1986-12-18 Method for producing selected polypeptides in virally infected insect cells and polypeptides isolated therefrom
BR8700563A BR8700563A (pt) 1985-12-18 1987-02-06 Processo para produzir um polipeptideo selecionado em uma celula de inseto hospedeira adequada;vetor recombinador,celula de inseto infectada,peptideo;molecula de polipeptideo;processo para produzir antigeno de superficie de virus de hepatite b em uma celula de inseto hospedeira adequada;celula de inseto hospedeira modificada,antigeno de superficie de virus de hepatite b
AU64806/90A AU6480690A (en) 1985-12-18 1990-10-19 Method for producing selected polypeptides in virally transformed insect cells and polypeptides isolated therefrom
AU52809/93A AU5280993A (en) 1985-12-18 1993-12-31 Method for producing selected polypeptides in virally transformed insect cells and polypeptides isolated therefrom
AU70329/96A AU7032996A (en) 1985-12-18 1996-10-21 Method for producing selected polypeptides in virally transformed insect cells and polypeptides isolated thereform

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81093885A 1985-12-18 1985-12-18
BR8700563A BR8700563A (pt) 1985-12-18 1987-02-06 Processo para produzir um polipeptideo selecionado em uma celula de inseto hospedeira adequada;vetor recombinador,celula de inseto infectada,peptideo;molecula de polipeptideo;processo para produzir antigeno de superficie de virus de hepatite b em uma celula de inseto hospedeira adequada;celula de inseto hospedeira modificada,antigeno de superficie de virus de hepatite b

Publications (1)

Publication Number Publication Date
BR8700563A true BR8700563A (pt) 1988-08-23

Family

ID=25664169

Family Applications (1)

Application Number Title Priority Date Filing Date
BR8700563A BR8700563A (pt) 1985-12-18 1987-02-06 Processo para produzir um polipeptideo selecionado em uma celula de inseto hospedeira adequada;vetor recombinador,celula de inseto infectada,peptideo;molecula de polipeptideo;processo para produzir antigeno de superficie de virus de hepatite b em uma celula de inseto hospedeira adequada;celula de inseto hospedeira modificada,antigeno de superficie de virus de hepatite b

Country Status (6)

Country Link
EP (1) EP0228036A3 (pt)
JP (1) JPS63167797A (pt)
KR (1) KR950001993B1 (pt)
AU (4) AU599348B2 (pt)
BR (1) BR8700563A (pt)
IE (1) IE60285B1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL80529A0 (en) * 1985-11-14 1987-02-27 Daiichi Seiyaku Co Method of producing peptides
EP0260090A3 (en) * 1986-09-08 1988-07-27 David H.L. Bishop Expression of hepatitis b viral antigens from recombinant baculovirus vectors
IL84154A0 (en) * 1986-10-16 1988-03-31 Microgenesys Inc Polypeptides derived from the envelope gene of human immunodeficiency virus in recombinant baculovirus infected insect cells and vaccines against acquired immune deficiency syndrome containing the same
AU625713B2 (en) * 1988-02-19 1992-07-16 Microgenesys, Inc. Method for producing recombinant protein derived from the circumsporozoite gene of plasmodium falciparum
GB8810808D0 (en) * 1988-05-06 1988-06-08 Wellcome Found Vectors
JP2511494B2 (ja) * 1988-05-12 1996-06-26 善治 松浦 日本脳炎ウイルス表面抗原蛋白質の製造法
FR2631974B1 (fr) * 1988-05-31 1992-12-11 Agronomique Inst Nat Rech Baculovirus modifie, son procede de preparation et son application en tant que vecteur d'expression de genes
AU4647889A (en) * 1988-11-18 1990-06-12 Cetus Corporation Insect signal peptide mediated secretion of recombinant proteins
US5272063A (en) * 1988-11-22 1993-12-21 Syntex (U.S.A.) Inc. Process of making human nerve growth factor
FR2645173B1 (fr) * 1989-03-29 1994-06-17 Pasteur Institut Clonage et expression de genes codant pour des peptides et/ou des fragments de peptides du virus mokola, application a la preparation d'un v
KR970005049B1 (ko) * 1990-07-16 1997-04-11 더 리젠츠 오브 더 유니벌시티 오브 캘리포니아 바쿨로비루스 발현 시스템, 이 벡터 시스템을 포함하는 이종성 무척추동물 숙주세포, 상기 시스템에 의해 생산되는 가용성의 정제된 야생형 망막아세포종 폴리펩티드 및 이 폴리펩티드의 생산 방법
TW502065B (en) * 1993-05-28 2002-09-11 American Cyanamid Co Gene insertion by direct ligation in vitro

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2480780B1 (fr) * 1980-04-22 1985-12-06 Pasteur Institut Procede de transformation de cellules, notamment eucaryotes, par un adn circulaire tel que celui du virus de l'hepatite b et preparations contenant les produits d'expression desdits adn
ZW18282A1 (en) * 1981-08-31 1983-03-23 Genentech Inc Preparation of polypeptides in vertebrate cell culture
JPS5980615A (ja) * 1982-10-29 1984-05-10 Takeda Chem Ind Ltd Ｄｎａおよびその用途
ATE78293T1 (de) * 1983-05-27 1992-08-15 Texas A & M Univ Sys Verfahren zur herstellung eines rekombinanten baculovirus-expressionsvektors.
DK518384A (da) * 1984-01-31 1985-07-01 Idaho Res Found Vektor til fremstilling af et gen-produkt i insektceller, fremgangsmaade til dens fremstilling samt dens anvendelse
US4777240A (en) * 1984-03-08 1988-10-11 Scripps Clinic And Research Foundation SV40 expression vector containing HBxAg as an expression marker
JPS619288A (ja) * 1984-06-21 1986-01-16 Dai Ichi Seiyaku Co Ltd ペプチド類の製法
JPS62501071A (ja) * 1984-10-30 1987-04-30 オンコゲン 成長因子活性を有する新規なポリペプチド及び該ポリペプチドをコ−ドする核酸配列

Also Published As

Publication number Publication date
KR870006189A (ko) 1987-07-09
IE863325L (en) 1987-06-18
EP0228036A2 (en) 1987-07-08
AU6669586A (en) 1987-06-25
IE60285B1 (en) 1994-06-29
AU599348B2 (en) 1990-07-19
JPS63167797A (ja) 1988-07-11
KR950001993B1 (ko) 1995-03-08
AU5280993A (en) 1994-03-17
AU6480690A (en) 1991-02-07
EP0228036A3 (en) 1988-09-07
AU7032996A (en) 1997-01-09

Similar Documents

Publication Publication Date Title
DE10399037I2 (de) Rekombinante Virusproteine begleitet von lymphadenopathischem Sydrom und/oder "Acquired Immune Deficiency Syndrome" (AIDS).
DE3650175D1 (de) Synthetische antigene zum nachweis von aids.
BR8702151A (pt) Processo de controle do peso molecular de oxidos polialquenicos
FR2480779B2 (fr) Vecteur contenant une sequence nucleotidique de l'antigene de surface du virus de l'hepatite b et procede de fabrication d'une molecule immunogene mettant en oeuvre ce vecteur
ATE173275T1 (de) Von einem retrovirus aus der hiv-gruppe abgeleitete peptide und deren verwendung
FI871362L (fi) Virusvaccin.
DK61595A (da) Rekombinant DNA-molekyler, værtscelletransformering dermed, værtsceller indeholdende disse samt fremgangsmåde til fremstilling af et polypeptid af IFN-alfa-typen
FI894580A7 (fi) Non-A, non-B-hepatitisvirusantigeenipeptidi
ES2029171A6 (es) Un procedimiento para preparar un polipeptido virico de hepatitis no a y no b post-transfusional (pt-nanbh)
DE3676052D1 (de) Massenpolymerisation von dicyclopentadien.
NZ216737A (en) Dna sequence, transformed cells and expressed proteins antigenic to anti-bovine diarrhea virus antibodies
DE3574896D1 (de) Verwertung von thermischer energie.
BR9202024A (pt) Virus de apivox recombinante,cultura de celulas eucariotica infectadas por um virus de avipox,vacina,sequencia de transferencia e plasmideo
DK345685D0 (da) Hepatitis b vaccine
BR8903279A (pt) Processo para preparar copoliesteres termoplasticos segmentados,elastomericos
DK427985D0 (da) Fremgangsmaade til optisk paavisning af et protein eller en nucleinsyre i en matrix
BR8201840A (pt) Processo para detectar presenc de virus de hepatite b processo para detectar sequencia conhecida de dna conjunto para diagnostico e processo para identificar portador humano de virus de hepatite b
FI892683A7 (fi) Menetelmä ei-hyperglykosyloitujen hepatiitti-B-virusproteiinien tuottamiseksi
BR8403645A (pt) Processo para aperfeicoar o rendimento de um material de fluoreto solido,pobre em sodio,a partir de uma solucao compreendendo especies contendo sodio,aluminio e fluor
FI861128L (fi) Monoklonaaliset vasta-aineet natriumdiureesia lisääviä nisäkkäiden sydäneteisen peptidejä kohtaan
IE863325L (en) Producing polypeptides in virally infected insect cells
DK288887D0 (da) Pseudorabies-virusprotein
PT81150B (pt) Processo para a preparacao duma vacina contra o virus da hepatite a em primatas
ATE360709T1 (de) Synthetische antigene zum nachweis von antikörpern mit immunreaktivität gegen hiv-virus
FI870501A0 (fi) Menetelmä melanoomaan liittyvän p97-antigeenin antigeenisen sukulaispeptidin tai -proteiinin valmistamiseksi, sekä siinä käyttökelpoiset yhdistelmävirukset, yhdistelmävektorit ja isäntäsolut

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
FC Decision: refusal